Stock 300147 XIANGXUE PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Xiangxue Pharmaceutical Co.,Ltd.

Equities

300147

CNE100000Y92

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
3.67 CNY -1.87% Intraday chart for Xiangxue Pharmaceutical Co.,Ltd. +6.07% -28.74%
Apr. 29 Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 24 Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,030 5,783 5,842 5,266 3,961 3,406
Enterprise Value (EV) 1 6,501 7,941 9,142 8,347 6,252 5,689
P/E ratio 68.2 x 73.8 x 59.7 x -7.76 x -7.49 x -8.73 x
Yield 0.55% 0.52% - - - -
Capitalization / Revenue 1.61 x 2.08 x 1.9 x 1.77 x 1.81 x 1.48 x
EV / Revenue 2.6 x 2.85 x 2.98 x 2.81 x 2.86 x 2.47 x
EV / EBITDA 17.7 x 26.1 x 20.5 x 68.4 x 168 x 15.4 x
EV / FCF -48.8 x 27.9 x -8.58 x 154 x 9.81 x -14.2 x
FCF Yield -2.05% 3.59% -11.6% 0.65% 10.2% -7.04%
Price to Book 1.17 x 1.66 x 1.5 x 2.63 x 1.62 x 1.73 x
Nbr of stocks (in thousands) 656,337 652,709 652,709 652,594 652,511 661,279
Reference price 2 6.140 8.860 8.950 8.070 6.070 5.150
Announcement Date 4/29/19 5/19/20 4/28/21 4/22/22 4/21/23 4/24/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,504 2,786 3,072 2,971 2,187 2,299
EBITDA 1 368.2 304.4 445 122.1 37.13 369.6
EBIT 1 256.1 190.2 311.8 -22.39 -197.4 137
Operating Margin 10.23% 6.82% 10.15% -0.75% -9.03% 5.96%
Earnings before Tax (EBT) 1 112 121.1 166.1 -635.8 -514.7 -389
Net income 1 56.44 79.97 98.42 -688.5 -533.2 -389
Net margin 2.25% 2.87% 3.2% -23.18% -24.38% -16.92%
EPS 2 0.0900 0.1200 0.1500 -1.040 -0.8100 -0.5900
Free Cash Flow 1 -133.3 285.1 -1,065 54.29 637.4 -400.4
FCF margin -5.32% 10.23% -34.67% 1.83% 29.14% -17.41%
FCF Conversion (EBITDA) - 93.65% - 44.47% 1,716.71% -
FCF Conversion (Net income) - 356.44% - - - -
Dividend per Share 2 0.0340 0.0460 - - - -
Announcement Date 4/29/19 5/19/20 4/28/21 4/22/22 4/21/23 4/24/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -54.38
Net margin -
EPS 2 -0.0820
Dividend per Share -
Announcement Date 4/28/22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2,471 2,158 3,300 3,081 2,291 2,284
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.711 x 7.09 x 7.414 x 25.24 x 61.71 x 6.179 x
Free Cash Flow 1 -133 285 -1,065 54.3 637 -400
ROE (net income / shareholders' equity) 2.23% 3.19% 3.39% -16.5% -15.4% -15.7%
ROA (Net income/ Total Assets) 1.79% 1.42% 2.14% -0.12% -1.19% 0.97%
Assets 1 3,150 5,614 4,605 580,008 44,796 -40,046
Book Value Per Share 2 5.260 5.350 5.950 3.070 3.750 2.980
Cash Flow per Share 2 1.000 0.7600 1.000 0.2000 0.2600 0.2300
Capex 1 495 661 707 563 367 56
Capex / Sales 19.78% 23.73% 23.03% 18.94% 16.79% 2.44%
Announcement Date 4/29/19 5/19/20 4/28/21 4/22/22 4/21/23 4/24/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
XIANGXUE PHARMACEUTICAL CO.,LTD. Stock Xiangxue Pharmaceutical Co.,Ltd.
-28.74% 335M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+39.33% 6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-18.38% 4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.17% 3.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+3.98% 3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.41% 2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+48.74% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.82% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-1.24% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.96% 1.6B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 300147 Stock
  4. Financials Xiangxue Pharmaceutical Co.,Ltd.